Respiratory Support and Sleep Centre (RSSC), Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK
Respiratory Support and Sleep Centre (RSSC), Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
BMJ Case Rep. 2021 Dec 31;14(12):e246469. doi: 10.1136/bcr-2021-246469.
We present the case of a 65-year-old woman diagnosed with rapid eye movement sleep behaviour disorder (REMBD) based on typical symptoms and confirmed with an inpatient polysomnogram. She was prescribed clonazepam and later temazepam but continued to have intrusive symptoms. She subsequently recalled that the onset of dream enactment coincided with starting high-dose omeprazole for acid reflux. With this insight, she stopped the omeprazole. Within days, the dream enactment and nocturnal movements subsided. She stopped taking the temazepam and was symptom free for a few months. However, she was started on lansoprazole for recurrent dyspepsia. Once again she experienced violent movements in sleep. This is the first time an association between proton pump inhibitors (PPIs) and REMBD has been reported. PPIs have many effects on the central nervous system and should be considered as a possible provoking factor in people presenting with REMBD.
我们报告了一例 65 岁女性患者,根据典型症状和住院多导睡眠图检查诊断为快速眼动睡眠行为障碍(REMBD)。她服用了氯硝西泮,后来改为替马西泮,但侵入性症状仍持续存在。后来她回忆起,做噩梦的症状发作与开始服用大剂量奥美拉唑治疗胃酸反流同时发生。有了这一认识,她停止了服用奥美拉唑。几天之内,梦境和夜间动作就减少了。她停止服用替马西泮,几个月内都没有症状。然而,她因复发性消化不良开始服用兰索拉唑。她再次在睡眠中经历了剧烈的运动。这是首次报道质子泵抑制剂(PPIs)与 REMBD 之间存在关联。PPIs 对中枢神经系统有许多影响,应考虑将其作为 REMBD 患者的一个可能诱发因素。